Malignant pheochromocytoma and paraganglioma: A population level analysis of long‐term survival over two decades

Abstract

Malignant PHEO has a more aggressive course than malignant PGL; long-term survival has not improved over the last two decades. Multi-institutional efforts should be pursued to seek novel treatments.